How many days should aspirin be discontinued prior to an elective tracheostomy?

Aspirin Management Prior to Tracheostomy

For elective tracheostomy, aspirin should be discontinued 5-7 days before the procedure in most patients, though continuation may be safe in select cases depending on cardiovascular risk.

Primary Recommendation Based on Guidelines

The decision to hold aspirin before tracheostomy requires balancing bleeding risk against cardiovascular thrombotic risk. The most recent 2024 AHA/ACC guidelines provide clear direction for perioperative antiplatelet management in noncardiac surgery 1:

For Patients WITHOUT Prior PCI (Stents)

• Continue aspirin perioperatively if the patient has coronary artery disease (CAD) and the risk of cardiac events outweighs bleeding risk 1
• If aspirin must be stopped, discontinue ≤7 days before surgery 2
• The 2022 CHEST guidelines specifically recommend stopping aspirin ≤7 days (not 7-10 days) before elective noncardiac surgery when interruption is necessary 2

For Patients WITH Prior PCI (Stents)

• Continue aspirin (75-100 mg) if at all possible to reduce cardiac events - this is a Class 1 recommendation 1
• Only interrupt if bleeding risk clearly outweighs thrombotic risk
• If recent stent placement (<30 days BMS or <3 months DES), continuing dual antiplatelet therapy is recommended unless bleeding risk is prohibitive 1

Evidence Supporting Shorter Discontinuation Periods

The traditional 7-10 day holding period is outdated. Multiple studies demonstrate platelet function recovery occurs faster than previously believed:

• Platelet function normalizes within 4-6 days after aspirin cessation in most patients 3, 4
• Bleeding times normalize within 96 hours and platelet function tests within 144 hours (6 days) 5
• One study demonstrated safe surgery at a median of 5 days after aspirin cessation without perioperative complications 3

Tracheostomy-Specific Evidence

Recent data specifically for tracheostomy is reassuring. A 2026 study comparing aspirin continuation versus discontinuation in open tracheostomy found:

• No major or minor bleeding events in patients who continued low-dose aspirin (81 mg) 6
• The discontinuation group had 6.3% major bleeding and 6.3% minor bleeding (not statistically significant) 6
• This supports that continuation of low-dose aspirin may be safe for tracheostomy 6

Clinical Algorithm for Decision-Making

Step 1: Assess Cardiovascular Risk

• High-risk patients (recent MI, prior PCI with stents, active CAD): Strongly favor continuing aspirin
• Low-risk patients (aspirin for primary prevention only): Can safely discontinue

Step 2: Assess Bleeding Risk of Tracheostomy

• Open tracheostomy is generally considered moderate bleeding risk
• Percutaneous tracheostomy may have slightly different risk profile
• Consider patient factors: coagulopathy, thrombocytopenia, concurrent anticoagulation

Step 3: Make Decision

For patients with prior PCI or high cardiovascular risk:

• Continue aspirin through surgery (Class 1 recommendation) 1

For patients without stents taking aspirin for secondary CAD prevention:

• Consider continuing aspirin if bleeding risk is acceptable 1
• If discontinuation chosen: stop 5-7 days before surgery 2, 3, 5

For patients on aspirin for primary prevention only:

• Discontinue 5-7 days before surgery 2
• Resume 24 hours postoperatively once hemostasis secured

Important Caveats

• Individual platelet function varies significantly: Up to 56% of patients taking aspirin show normal platelet function on testing 7, suggesting aspirin resistance
• The 10-day rule is obsolete: Modern evidence supports 5-7 days maximum 2, 3, 5
• Never discontinue aspirin in patients with recent stents (<30 days BMS, <3 months DES) unless bleeding risk is life-threatening 1
• Coordinate with cardiology for patients with complex coronary disease or recent PCI

Practical Implementation

For a typical elective tracheostomy patient on aspirin for secondary prevention without recent stents:

• Stop aspirin 5-7 days preoperatively if discontinuation is chosen
• Resume within 24 hours postoperatively once surgical hemostasis is confirmed
• Consider continuing aspirin perioperatively in high cardiovascular risk patients, as recent tracheostomy data suggests this is safe 6